Find trials
Search tips

Prospective Biospecimens for New Technology and Platform Development

Overview

About this study

The purpose of this study is to develop and optimization of new technologies and protocols is a critical part of what is done in the Proteomics Core.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • The material will be accrued based on availability at autopsy or post-surgery without discrimination.
  • ≥ 18 Years of age.

Exclusion Criteria: 

  • ≤ 18 Years of age.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/1/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Akhilesh Pandey, M.D., Ph.D.

Open for enrollment

Contact information:

DLMP Research and Innovation Office

(507) 284-9080

DLMPRIO@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20567465

Mayo Clinic Footer